Literature DB >> 17006989

Prevalence of H pylori associated "high risk gastritis" for development of gastric cancer in patients with normal endoscopic findings.

Andreas Leodolter1, Matthias P Ebert, Ulrich Peitz, Kathlen Wolle, Stefan Kahl, Michael Vieth, Peter Malfertheiner.   

Abstract

AIM: To investigate the prevalence of H pylori associated corpus-predominant gastritis (CPG) or pangastritis, severe atrophy, and intestinal metaplasia (IM) in patients without any significant abnormal findings during upper-GI endoscopy.
METHODS: Gastric biopsies from 3548 patients were obtained during upper GI-endoscopy in a 4-year period. Two biopsies from antrum and corpus were histologically assessed according to the updated Sydney-System. Eight hundred and forty-five patients (mean age 54.8 +/- 2.8 years) with H pylori infection and no peptic ulcer or abnormal gross findings in the stomach were identified and analyzed according to gastritis phenotypes using different scoring systems.
RESULTS: The prevalence of severe H pylori associated changes like pangastritis, CPG, IM, and severe atrophy increased with age, reaching a level of 20% in patients of the age group over 45 years. No differences in frequencies between genders were observed. The prevalence of IM had the highest increase, being 4-fold higher at the age of 65 years versus in individuals less than 45 years.
CONCLUSION: The prevalence of gastritis featuring at risk for cancer development increases with age. These findings reinforce the necessity for the histological assessment, even in subjects with normal endoscopic appearance. The age-dependent increase in prevalence of severe histopathological changes in gastric mucosa, however, does not allow estimating the individual risk for gastric cancer development--only a proper follow-up can provide this information.

Entities:  

Mesh:

Year:  2006        PMID: 17006989      PMCID: PMC4088234          DOI: 10.3748/wjg.v12.i34.5509

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  11 in total

1.  Gastric carcinoma risk index in patients infected with Helicobacter pylori.

Authors:  A Meining; E Bayerdörffer; P Müller; S Miehlke; N Lehn; D Hölzel; R Hatz; M Stolte
Journal:  Virchows Arch       Date:  1998-04       Impact factor: 4.064

2.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

3.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

4.  Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients.

Authors:  A G Meining; E Bayerdörffer; M Stolte
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-07       Impact factor: 2.566

5.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

Authors:  Benjamin Chun-Yu Wong; Shiu Kum Lam; Wai Man Wong; Jian Shun Chen; Ting Ting Zheng; Rui E Feng; Kam Chuen Lai; Wayne Hsing Cheng Hu; Siu Tsan Yuen; Suet Yi Leung; Daniel Yee Tak Fong; Joanna Ho; Chi Kong Ching; Jun Shi Chen
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

6.  Comparative classification and grading of Helicobacter pylori gastritis in patients with gastric cancer and patients with functional dyspepsia.

Authors:  A Meining; A Kompisch; M Stolte
Journal:  Scand J Gastroenterol       Date:  2003-07       Impact factor: 2.423

Review 7.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention.

Authors:  P Correa
Journal:  Cancer Res       Date:  1992-12-15       Impact factor: 12.701

8.  Helicobacter pylori infection and the risk of gastric carcinoma.

Authors:  J Parsonnet; G D Friedman; D P Vandersteen; Y Chang; J H Vogelman; N Orentreich; R K Sibley
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

9.  Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial.

Authors:  Catherine Ley; Alejandro Mohar; Jeannette Guarner; Roberto Herrera-Goepfert; Luz Sanchez Figueroa; David Halperin; Iain Johnstone; Julie Parsonnet
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-01       Impact factor: 4.254

Review 10.  Alteration of histological gastritis after cure of Helicobacter pylori infection.

Authors:  M Hojo; H Miwa; T Ohkusa; R Ohkura; A Kurosawa; N Sato
Journal:  Aliment Pharmacol Ther       Date:  2002-11       Impact factor: 8.171

View more
  7 in total

1.  Endoscopic gastritis: what does it mean?

Authors:  Sun-Young Lee
Journal:  Dig Dis Sci       Date:  2011-08       Impact factor: 3.199

2.  Are clinical features able to predict Helicobacter pylori gastritis patterns? Evidence from tertiary centers.

Authors:  Marilia Carabotti; Edith Lahner; Barbara Porowska; Enzo Colacci; Paolo Trentino; Bruno Annibale; Carola Severi
Journal:  Intern Emerg Med       Date:  2014-02-19       Impact factor: 3.397

3.  Helicobacter pylori and precancerous conditions of the stomach: the frequency of infection in a cross-sectional study of 79 consecutive patients with chronic antral gastritis in Yaoundé, Cameroon.

Authors:  Firmin Ankouane; Dominique Noah Noah; Félicien Ntoné Enyime; Carole Menzy Ndjollé; Roger Nsenga Djapa; Bernadette Ngo Nonga; Oudou Njoya; Elie Claude Ndjitoyap Ndam
Journal:  Pan Afr Med J       Date:  2015-01-20

4.  AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors.

Authors:  Osama Altayar; Perica Davitkov; Shailja C Shah; Andrew J Gawron; Douglas R Morgan; Kevin Turner; Reem A Mustafa
Journal:  Gastroenterology       Date:  2019-12-06       Impact factor: 22.682

5.  Histopathological Assessment of Dyspepsia in the Absence of Endoscopic Mucosal Lesions.

Authors:  Hosam M Dawod; Mahmoud W Emara
Journal:  Euroasian J Hepatogastroenterol       Date:  2016-12-01

6.  Advancing the Science in Gastric Pre-Neoplasia: Study Design Considerations.

Authors:  Perica Davitkov; Osama Altayar; Shailja C Shah; Andrew J Gawron; Reem A Mustafa; Shahnaz Sultan; Douglas R Morgan
Journal:  Gastroenterology       Date:  2019-12-06       Impact factor: 22.682

7.  Identification of Gastritis Subtypes by Convolutional Neuronal Networks on Histological Images of Antrum and Corpus Biopsies.

Authors:  Georg Steinbuss; Katharina Kriegsmann; Mark Kriegsmann
Journal:  Int J Mol Sci       Date:  2020-09-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.